Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
US8871250B2 · kind B2 · utility
1Cited by
19References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2006 |
| Grant date | Oct 28, 2014 |
| Priority date | — |
| Expiry date | Feb 22, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4725
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.